![]() Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products. | ![]() Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. | ||
Founding Date | Founding Date 1996 | Founding Date 1978 | Founding Date 1990 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations CN HQ | Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more | Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US |
Employees | Employees 1,384 | Employees 9,500 | Employees 7,9267% increase |
Valuation ($) | Valuation ($) 805.7 m | Valuation ($) 5.6 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥752m (FY, 2024) | Revenue (est.) $3.3b (FY, 2025) | Revenue (est.) ₹105.6b (FY, 2026) |
Cost of goods | Cost of goods ¥331m (FY, 2024) | Cost of goods $1.7b (FY, 2025) | Cost of goods ₹40.9b (FY, 2026) |
Gross profit | Gross profit ¥431.7m (FY, 2024) | Gross profit $1.7b (FY, 2025) | Gross profit ₹69.7b (FY, 2026) |
Net income | Net income ¥76.7m (FY, 2024) | Net income $407m (FY, 2025) | Net income ₹25.7b (FY, 2026) |

Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
View company
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
View company